Home > > > > > > Report Detail

Global HIV Treatment Market: Analysis By Product (Atripla, Biktarvy, Descovy, Genovya, Odefsey, Truvada, Sunlenca (Lenacapavir), Dovato, Juluca, Tivicay, Triumeq, Cabenuva, VH184, Capsid, bNAbs, Islatravir, and Generics), By Region (The US, and EU + ROW) Size and Trends with Impact of COVID-19 and Forecast up to 2030

Publisher Name :
Date: 30-May-2023
No. of pages: 169

The global HIV treatment market in 2022 stood at US$22.38 billion, and is likely to reach US$25.49 billion by 2030. HIV treatment, also known as antiretroviral therapy (ART), involves the use of medications to manage the human immunodeficiency virus (HIV). Antiretroviral therapy (ART) for HIV treatment is a combination of drugs that work to slow the rate at which the virus replicates within the body, preventing it from progressing to AIDS. This helps maintain the immune system's health, reduces the risk of transmission, and enhances the patient's quality of life.

In recent years, the surge in demand for HIV treatment is driven by a rise in global HIV prevalence, enhanced diagnostic capabilities, progress in treatment methodologies, and the advent of innovative drugs with higher efficacy and resistance profiles. This is further bolstered by heightened public awareness and healthcare initiatives. To counter this, UNAIDS has set in motion the Fast-Track strategy with the objective of eradicating the AIDS epidemic as a public health threat by 2030. This strategy focuses on optimized resource allocation and expedited responses, underlining its significance in achieving the Sustainable Development Goals, specifically, ensuring health and well-being for all. Despite the absence of a definitive cure for HIV at present, ongoing research and development activities offer hope for more efficient treatments in the future. The global HIV treatment market is projected to grow at a CAGR of 1.42% during the forecast period of 2023-2030.

Market Segmentation Analysis:

By Product: The market report has segmented the global HIV treatment market into seventeen segments namely, Biktarvy, Cabenuva, Sunlenca (lenacapavir), Islatravir, Genvoya, Odefsey, bNAbs, Descovy, Capsid, Dovato, Tivicay, Juluca, VH184, Triumeq, Atripla, Truvada, and Generics. In 2022, the Biktarvy segment dominates the market share in 2022, the Biktarvy, a single-tablet regimen for HIV, holds the largest market share due to its high efficacy, minimal side effects, and convenience, coupled with its proven effectiveness across diverse patient populations, making it a preferred choice for both clinicians and patients. The HIV treatment market is poised for significant advancements due to relentless research and development activities. By the end of the 2030s, this market is expected to be augmented by the launch of novel and advanced HIV treatment drugs, thereby strengthening our global response to this major health concern. The forthcoming period is expected to witness the debut of several groundbreaking products like Sunlenca (lenacapavir), VH184, Capsid, bNAbs, and Islatravir. Concurrently, the patents of numerous existing drugs such as Descovy, Tivicay, Triumeq, Juluca, and Dovato are anticipated to expire, thereby facilitating the introduction of generic substitutes in the market.

By Region: According to this report, the global HIV treatment market can be divided into two major regions: The US, and European Union + Rest of the World (EU + ROW).

In 2022, the US dominated the global HIV treatment market due to its broad coverage of health insurance, effective HIV awareness programs, and the presence of major pharmaceutical companies engaged in HIV research and drug development.

The US HIV treatment market is expected to grow at the fastest CAGR from 2023 to 2030 due to ongoing advancements in medical technology and pharmaceuticals, spurred by continuous research from US-based companies, are leading to the development of more effective antiretroviral drugs, fueling market expansion. Moreover, enhanced HIV screening and testing initiatives are set to increase the number of diagnosed cases, thus driving demand for treatment drugs.

Global HIV Treatment Market Dynamics:

Growth Drivers: The HIV treatment market has experienced significant growth due to the development of more effective and tolerable antiretroviral treatments (ARTs), increased availability and affordability of ARTs, and growing awareness and prevention efforts. Ongoing development of innovative medications is expected to sustain market growth, benefiting individuals worldwide by improving treatment accessibility, affordability, and quality of life, while also preventing drug resistance and promoting long-term health outcomes. This growth signifies progress in the fight against HIV and the provision of necessary treatment for improved patient outcomes. Further, the market is expected to grow owing to rising HIV prevalence, rising disposable income, increased government funding and initiatives, expansion of generic drugs, growing awareness and testing, public-private partnerships, etc. in recent years.

Challenges: Drug-resistant strains of HIV pose a major challenge to the global HIV treatment market, necessitating continuous research, development of new antiretroviral therapies, and monitoring of resistance trends. Adherence to treatment regimens and ensuring the quality and availability of medications are crucial to mitigate drug resistance. Addressing these challenges is vital for maintaining the effectiveness of current treatments and developing novel therapies capable of combating drug-resistant HIV strains. Additionally, other factors like stigma, discrimination, and access to treatment, loss of patent protection, etc. are other challenges to the market.

Market Trends: Advances in gene therapy have the potential to revolutionize the global HIV treatment market, offering more targeted and effective treatment options, potential functional cures, and improved patient outcomes. Promising candidates in development indicate significant growth opportunities and market potential, transforming the treatment landscape and enhancing the quality of life for individuals living with HIV. More trends in the market are believed to grow the HIV treatment market during the forecasted period, which may include increasing penetration of artificial intelligence, increasing adoption of telemedicine, development of long-acting injectable, focus on combination therapies, etc.

Impact Analysis of COVID-19 and Way Forward:

The COVID-19 pandemic has had a mixed impact on the global HIV treatment market, resulting in disruptions to medication supply chains and patient care, but also driving increased public health awareness, telemedicine adoption, and accelerated pharmaceutical innovation amid collaborative efforts for equitable treatment distribution. The post-COVID impact on the HIV treatment market is expected to bring improved access to care, increased innovation, greater collaboration, enhanced supply chain resilience, and a focus on achieving health equity.

Competitive Landscape and Recent Developments:

The global HIV treatment market is consolidated, with major pharmaceutical companies like Gilead Sciences, ViiV Healthcare, and Merck leading the market with their comprehensive drug portfolios. These firms, with expansive drug portfolios, significantly shape the market. Notably, Gilead's Biktarvy and ViiV's Dovato offer effective treatment options with limited side effects. These companies continue to innovate, investing in research and development to improve patient outcomes and address persistent HIV challenges. Gilead's recent FDA application for lenacapavir, a long-acting HIV-1 capsid inhibitor, exemplifies their commitment to innovation. These ongoing efforts are instrumental in shaping the future of the global HIV treatment market.

Further, key players in the global HIV treatment market are:

Gilead Sciences, Inc.

GlaxoSmithKline Plc (ViiV Healthcare)

Merck & Co., Inc.

Abbott Laboratories

AbbVie Inc.

TEVA Pharmaceutical Industries Limited

Johnson & Johnson (Janssen Pharmaceuticals)

Boehringer Ingelheim

Cipla Limited

Viatris Inc.

Bristol-Myers Squibb Company

Hetero Drugs Limited

Smaller players and generic manufacturers contribute to accessibility and affordability, improving treatment outcomes globally. Collaborations and partnerships, such as the Medicines Patent Pool (MPP) and ViiV Healthcare, facilitate the production of affordable generic versions of HIV medications. Key generic players include Mylan, Cipla, Aurobindo Pharma, Hetero Drugs, and Sun Pharmaceutical Industries. Partnerships between pharmaceutical companies, NGOs, governments, and global health organizations drive research, development, and access to HIV treatments, ensuring broader availability and better patient care.

Global HIV Treatment Market: Analysis By Product (Atripla, Biktarvy, Descovy, Genovya, Odefsey, Truvada, Sunlenca (Lenacapavir), Dovato, Juluca, Tivicay, Triumeq, Cabenuva, VH184, Capsid, bNAbs, Islatravir, and Generics), By Region (The US, and EU + ROW) Size and Trends with Impact of COVID-19 and Forecast up to 2030

Table of Contents

1. Executive Summary
2. Introduction
2.1 HIV Treatment: An Overview
2.1.1 Definition of HIV Treatment
2.1.2 Goals of HIV Treatment
2.1.3 HIV Treatment By Medication Class
2.2 HIV Treatment Segmentation: An Overview
2.2.1 HIV Treatment Segmentation By Product
3. Global Market Analysis
3.1 Global HIV Treatment Market: An Analysis
3.1.1 Global HIV Treatment Market: An Overview
3.1.2 Global HIV Treatment Market by Value
3.1.3 Global HIV Treatment Market by Product (Biktarvy, Genvoya, Triumeq, Dovato, Tivicay, Odefsey, Juluca, Descovy, Cabenuva, Truvada, Atripla, and Generics)
3.1.4 Global HIV Treatment Market by Region (the US, and European Union + Rest of World)
3.2 Global HIV Treatment Market: Product Analysis
3.2.1 Global HIV Treatment Market by Product: An Overview
3.2.2 Global Biktarvy HIV Treatment Market by Value
3.2.3 Global Genvoya HIV Treatment Market by Value
3.2.4 Global Triumeq HIV Treatment Market by Value
3.2.5 Global Dovato HIV Treatment Market by Value
3.2.6 Global Tivicay HIV Treatment Market by Value
3.2.7 Global Odefsey HIV Treatment Market by Value
3.2.8 Global Juluca HIV Treatment Market by Value
3.2.9 Global Descovy HIV Treatment Market by Value
3.2.10 Global Cabenuva HIV Treatment Market by Value
3.2.11 Global Truvada HIV Treatment Market by Value
3.2.12 Global Atripla HIV Treatment Market by Value
3.2.13 Global Sunlenca (Lenacapavir) HIV Treatment Market by Value
3.2.14 Global VH184 HIV Treatment Market by Value
3.2.15 Global Capsid HIV Treatment Market by Value
3.2.16 Global bNAbs HIV Treatment Market by Value
3.2.17 Global Islatravir HIV Treatment Market by Value
3.2.18 Global Generics HIV Treatment Market by Value
4. Regional Market Analysis
4.1 The US HIV Treatment Market: An Analysis
4.1.1 The US HIV Treatment Market: An Overview
4.1.2 The US HIV Treatment Market by Value
4.1.3 The US HIV Treatment Market by Product (Biktarvy, Genvoya, Triumeq, Odefsey, Tivicay, Dovato, Juluca, Descovy, Cabenuva, Truvada, Atripla, and Generics)
4.2 The US HIV Treatment Market: Product Analysis
4.2.1 The US HIV Treatment Market by Product: An Overview
4.2.2 The US Biktarvy HIV Treatment Market by Value
4.2.3 The US Genvoya HIV Treatment Market by Value
4.2.4 The US Triumeq HIV Treatment Market by Value
4.2.5 The US Dovato HIV Treatment Market by Value
4.2.6 The US Tivicay HIV Treatment Market by Value
4.2.7 The US Odefsey HIV Treatment Market by Value
4.2.8 The US Juluca HIV Treatment Market by Value
4.2.9 The US Descovy HIV Treatment Market by Value
4.2.10 The US Cabenuva HIV Treatment Market by Value
4.2.11 The US Truvada HIV Treatment Market by Value
4.2.12 The US Atripla HIV Treatment Market by Value
4.2.13 The US Sunlenca (Lenacapavir) HIV Treatment Market by Value
4.2.14 The US VH184 HIV Treatment Market by Value
4.2.15 The US Capsid HIV Treatment Market by Value
4.2.16 The US bNAbs HIV Treatment Market by Value
4.2.17 The US Islatravir HIV Treatment Market by Value
4.2.18 The US Generics HIV Treatment Market by Value
4.3 European Union + Rest of World HIV Treatment Market: An Analysis
4.3.1 European Union + Rest of World HIV Treatment Market: An Overview
4.3.2 European Union + Rest of World HIV Treatment Market by Value
4.3.3 European Union + Rest of World HIV Treatment Market by Product (Biktarvy, Dovato, Triumeq, Tivicay, Genvoya, Odefsey, Juluca, Descovy, Cabenuva, Truvada, and Atripla)
4.4 European Union + Rest of World HIV Treatment Market: Product Analysis
4.4.1 European Union + Rest of World HIV Treatment Market by Product: An Overview
4.4.2 European Union + Rest of World Biktarvy HIV Treatment Market by Value
4.4.3 European Union + Rest of World Genvoya HIV Treatment Market by Value
4.4.4 European Union + Rest of World Triumeq HIV Treatment Market by Value
4.4.5 European Union + Rest of World Dovato HIV Treatment Market by Value
4.4.6 European Union + Rest of World Tivicay HIV Treatment Market by Value
4.4.7 European Union + Rest of World Odefsey HIV Treatment Market by Value
4.4.8 European Union + Rest of World Juluca HIV Treatment Market by Value
4.4.9 European Union + Rest of World Descovy HIV Treatment Market by Value
4.4.10 European Union + Rest of World Cabenuva HIV Treatment Market by Value
4.4.11 European Union + Rest of World Truvada HIV Treatment Market by Value
4.4.12 European Union + Rest of World Atripla HIV Treatment Market by Value
4.4.13 European Union + Rest of World Sunlenca (Lenacapavir) HIV Treatment Market by Value
4.4.14 European Union + Rest of World VH184 HIV Treatment Market by Value
4.4.15 European Union + Rest of World Capsid HIV Treatment Market by Value
4.4.16 European Union + Rest of World bNAbs HIV Treatment Market by Value
4.4.17 European Union + Rest of World Islatravir HIV Treatment Market by Value
5. Impact of COVID-19
5.1 Impact of COVID-19 on Global HIV Treatment Market
5.2 Post-COVID-19 Impact on Global HIV Treatment Market
6. Market Dynamics
6.1 Growth Driver
6.1.1 Rising HIV Prevalence
6.1.2 Advancements in Antiretroviral Therapy (ART)
6.1.3 Rising Disposable Income
6.1.4 Increased Government Funding and Initiatives
6.1.5 Expansion of Generic Drugs
6.1.6 Growing Awareness and Testing
6.1.7 Public-private Partnerships
6.2 Challenges
6.2.1 Drug Resistance
6.2.2 Stigma, Discrimination, and Access to Treatment
6.2.3 Loss of Patent Protection
6.3 Market Trends
6.3.1 Increasing Penetration of Artificial Intelligence
6.3.2 Increasing Adoption of Telemedicine
6.3.3 Development of Long-acting Injectable
6.3.4 Advances in Gene Therapy
6.3.5 Focus on Combination Therapies
7. Competitive Landscape
7.1 Global HIV Treatment Market: Competitive Landscape
7.2 Global HIV Treatment Market Players: Approved Product List
8. Company Profiles
8.1 Gilead Sciences, Inc.
8.1.1 Business Overview
8.1.2 Sales by Product
8.1.3 Business Strategy
8.2 GlaxoSmithKline Plc (ViiV Healthcare)
8.2.1 Business Overview
8.2.2 Sales by Products
8.2.3 Business Strategy
8.3 Merck & Co., Inc.
8.3.1 Business Overview
8.3.2 Operating Segments
8.3.3 Business Strategy
8.4 Abbott Laboratories
8.4.1 Business Overview
8.4.2 Revenue by Category
8.4.3 Business Strategy
8.5 AbbVie Inc.
8.5.1 Business Overview
8.5.2 Operating Regions
8.5.3 Business Strategy
8.6 TEVA Pharmaceutical Industries Limited
8.6.1 Business Overview
8.6.2 Operating Segments
8.6.3 Business Strategy
8.7 Johnson & Johnson (Janssen Pharmaceuticals)
8.7.1 Business Overview
8.7.2 Business Segments
8.7.3 Business Strategy
8.8 Boehringer Ingelheim
8.8.1 Business Overview
8.8.2 Operating Business
8.8.3 Business Strategy
8.9 Cipla Limited
8.9.1 Business Overview
8.9.2 Operating Segments
8.9.3 Business Strategy
8.10 Viatris Inc.
8.10.1 Business Overview
8.10.2 Operating Segments
8.10.3 Business Strategy
8.11 Bristol-Myers Squibb Company
8.11.1 Business Overview
8.11.2 Revenue by Product
8.11.3 Business Strategy
8.12 Hetero Drugs Limited
8.12.1 Business Overview
8.12.2 Business Strategy

List of Figures
Figure 1: Goals of HIV Treatment
Figure 2: HIV Treatment by Medication Class
Figure 3: HIV Treatment Segmentation by Product
Figure 4: Global HIV Treatment Market by Value; 2020-2022 (US$ Billion)
Figure 5: Global HIV Treatment Market by Value; 2023-2030 (US$ Billion)
Figure 6: Global HIV Treatment Market by Product; 2022 (Percentage, %)
Figure 7: Global HIV Treatment Market by Region; 2022 (Percentage, %)
Figure 8: Global Biktarvy HIV Treatment Market by Value, 2020-2022 (US$ Billion)
Figure 9: Global Biktarvy HIV Treatment Market by Value, 2023-2030 (US$ Billion)
Figure 10: Global Genvoya HIV Treatment Market by Value, 2020-2022 (US$ Billion)
Figure 11: Global Genvoya HIV Treatment Market by Value, 2023-2030 (US$ Billion)
Figure 12: Global Triumeq HIV Treatment Market by Value, 2020-2022 (US$ Billion)
Figure 13: Global Triumeq HIV Treatment Market by Value, 2023-2030 (US$ Million)
Figure 14: Global Dovato HIV Treatment Market by Value, 2020-2022 (US$ Billion)
Figure 15: Global Dovato HIV Treatment Market by Value, 2023-2030 (US$ Billion)
Figure 16: Global Tivicay HIV Treatment Market by Value, 2020-2022 (US$ Billion)
Figure 17: Global Tivicay HIV Treatment Market by Value, 2023-2030 (US$ Million)
Figure 18: Global Odefsey HIV Treatment Market by Value, 2020-2022 (US$ Billion)
Figure 19: Global Odefsey HIV Treatment Market by Value, 2023-2030 (US$ Billion)
Figure 20: Global Juluca HIV Treatment Market by Value, 2020-2022 (US$ Million)
Figure 21: Global Juluca HIV Treatment Market by Value, 2023-2030 (US$ Million)
Figure 22: Global Descovy HIV Treatment Market by Value, 2020-2022 (US$ Million)
Figure 23: Global Descovy HIV Treatment Market by Value, 2023-2030 (US$ Million)
Figure 24: Global Cabenuva HIV Treatment Market by Value, 2020-2022 (US$ Million)
Figure 25: Global Cabenuva HIV Treatment Market by Value, 2023-2030 (US$ Billion)
Figure 26: Global Truvada HIV Treatment Market by Value, 2020-2022 (US$ Million)
Figure 27: Global Truvada HIV Treatment Market by Value, 2023-2030 (US$ Million)
Figure 28: Global Atripla HIV Treatment Market by Value, 2020-2022 (US$ Million)
Figure 29: Global Atripla HIV Treatment Market by Value, 2023-2030 (US$ Million)
Figure 30: Global Sunlenca (Lenacapavir) HIV Treatment Market by Value, 2023-2030 (US$ Million)
Figure 31: Global VH184 HIV Treatment Market by Value; 2030 (US$ Million)
Figure 32: Global Capsid HIV Treatment Market by Value; 2027-2030 (US$ Million)
Figure 33: Global bNAbs HIV Treatment Market by Value, 2027-2030 (US$ Million)
Figure 34: Global Islatravir HIV Treatment Market by Value; 2024-2030 (US$ Billion)
Figure 35: Global Generics HIV Treatment Market by Value, 2020-2022 (US$ Million)
Figure 36: Global Generics HIV Treatment Market by Value, 2023-2030 (US$ Million)
Figure 37: The US HIV Treatment Market by Value; 2020-2022 (US$ Billion)
Figure 38: The US HIV Treatment Market by Value; 2023-2030 (US$ Billion)
Figure 39: The US HIV Treatment Market by Product; 2022 (Percentage, %)
Figure 40: The US Biktarvy HIV Treatment Market by Value, 2020-2022 (US$ Billion)
Figure 41: The US Biktarvy HIV Treatment Market by Value, 2023-2030 (US$ Billion)
Figure 42: The US Genvoya HIV Treatment Market by Value, 2020-2022 (US$ Billion)
Figure 43: The US Genvoya HIV Treatment Market by Value, 2023-2030 (US$ Billion)
Figure 44: The US Triumeq HIV Treatment Market by Value, 2020-2022 (US$ Billion)
Figure 45: The US Triumeq HIV Treatment Market by Value, 2023-2030 (US$ Million)
Figure 46: The US Dovato HIV Treatment Market by Value, 2020-2022 (US$ Billion)
Figure 47: The US Dovato HIV Treatment Market by Value, 2023-2030 (US$ Billion)
Figure 48: The US Tivicay HIV Treatment Market by Value, 2020-2022 (US$ Billion)
Figure 49: The US Tivicay HIV Treatment Market by Value, 2023-2030 (US$ Million)
Figure 50: The US Odefsey HIV Treatment Market by Value, 2020-2022 (US$ Billion)
Figure 51: The US Odefsey HIV Treatment Market by Value, 2023-2030 (US$ Million)
Figure 52: The US Juluca HIV Treatment Market by Value, 2020-2022 (US$ Million)
Figure 53: The US Juluca HIV Treatment Market by Value, 2023-2030 (US$ Million)
Figure 54: The US Descovy HIV Treatment Market by Value, 2020-2022 (US$ Million)
Figure 55: The US Descovy HIV Treatment Market by Value, 2023-2030 (US$ Million)
Figure 56: The US Cabenuva HIV Treatment Market by Value, 2020-2022 (US$ Million)
Figure 57: The US Cabenuva HIV Treatment Market by Value, 2023-2030 (US$ Billion)
Figure 58: The US Truvada HIV Treatment Market by Value, 2020-2022 (US$ Million)
Figure 59: The US Truvada HIV Treatment Market by Value, 2023-2030 (US$ Million)
Figure 60: The US Atripla HIV Treatment Market by Value, 2020-2022 (US$ Million)
Figure 61: The US Atripla HIV Treatment Market by Value, 2023-2030 (US$ Million)
Figure 62: The US Sunlenca (Lenacapavir) HIV Treatment Market by Value, 2023-2030 (US$ Million)
Figure 63: The US VH184 HIV Treatment Market by Value, 2030 (US$ Million)
Figure 64: The US Capsid HIV Treatment Market by Value, 2027-2030 (US$ Million)
Figure 65: The US bNAbs HIV Treatment Market by Value, 2027-2030 (US$ Million)
Figure 66: The US Islatravir HIV Treatment Market by Value, 2024-2030 (US$ Million)
Figure 67: The US Generics HIV Treatment Market by Value, 2020-2022 (US$ Million)
Figure 68: The US Generics HIV Treatment Market by Value, 2023-2030 (US$ Million)
Figure 69: European Union + Rest of World HIV Treatment Market by Value; 2020-2022 (US$ Billion)
Figure 70: European Union + Rest of World HIV Treatment Market by Value; 2023-2030 (US$ Billion)
Figure 71: European Union + Rest of World HIV Treatment Market by Product; 2022 (Percentage, %)
Figure 72: European Union + Rest of World Biktarvy HIV Treatment Market by Value, 2020-2022 (US$ Billion)
Figure 73: European Union + Rest of World Biktarvy HIV Treatment Market by Value, 2023-2030 (US$ Billion)
Figure 74: European Union + Rest of World Genvoya HIV Treatment Market by Value, 2020-2022 (US$ Million)
Figure 75: European Union + Rest of World Genvoya HIV Treatment Market by Value, 2023-2030 (US$ Million)
Figure 76: European Union + Rest of World Triumeq HIV Treatment Market by Value, 2020-2022 (US$ Billion)
Figure 77: European Union + Rest of World Triumeq HIV Treatment Market by Value, 2023-2030 (US$ Million)
Figure 78: European Union + Rest of World Dovato HIV Treatment Market by Value, 2020-2022 (US$ Million)
Figure 79: European Union + Rest of World Dovato HIV Treatment Market by Value, 2023-2030 (US$ Billion)
Figure 80: European Union + Rest of World Tivicay HIV Treatment Market by Value, 2020-2022 (US$ Million)
Figure 81: European Union + Rest of World Tivicay HIV Treatment Market by Value, 2023-2030 (US$ Million)
Figure 82: European Union + Rest of World Odefsey HIV Treatment Market by Value, 2020-2022 (US$ Million)
Figure 83: European Union + Rest of World Odefsey HIV Treatment Market by Value, 2023-2030 (US$ Million)
Figure 84: European Union + Rest of World Juluca HIV Treatment Market by Value, 2020-2022 (US$ Million)
Figure 85: European Union + Rest of World Juluca HIV Treatment Market by Value, 2023-2030 (US$ Million)
Figure 86: European Union + Rest of World Descovy HIV Treatment Market by Value, 2020-2022 (US$ Million)
Figure 87: European Union + Rest of World Descovy HIV Treatment Market by Value, 2023-2030 (US$ Million)
Figure 88: European Union + Rest of World Cabenuva HIV Treatment Market by Value, 2020-2022 (US$ Million)
Figure 89: European Union + Rest of World Cabenuva HIV Treatment Market by Value, 2023-2030 (US$ Million)
Figure 90: European Union + Rest of World Truvada HIV Treatment Market by Value, 2020-2022 (US$ Million)
Figure 91: European Union + Rest of World Truvada HIV Treatment Market by Value, 2023-2025 (US$ Million)
Figure 92: European Union + Rest of World Atripla HIV Treatment Market by Value, 2020-2022 (US$ Million)
Figure 93: European Union + Rest of World Atripla HIV Treatment Market by Value, 2023-2030 (US$ Million)
Figure 94: European Union + Rest of World Sunlenca (Lenacapavir) HIV Treatment Market by Value, 2023-2030 (US$ Million)
Figure 95: European Union + Rest of World VH184 HIV Treatment Market by Value, 2030 (US$ Million)
Figure 96: European Union + Rest of World Capsid HIV Treatment Market by Value, 2027-2030 (US$ Million)
Figure 97: European Union + Rest of World bNAbs HIV Treatment Market by Value, 2027-2030 (US$ Million)
Figure 98: European Union + Rest of World Islatravir HIV Treatment Market by Value, 2024-2030 (US$ Million)
Figure 99: Global Number of HIV Patients (Living with & Newly Infected); 2021 (Million)
Figure 100: The US, and EU Number of HIV Patients (Prevalent, Diagnosed & Treated); 2021 (Million)
Figure 101: Global Coverage of Antiretroviral Treatment (ART); 2021 (Percentage, %)
Figure 102: Global Coverage of Antiretroviral Treatment (ART) Among Children & Prevention Of Mother-to-child Transmission (PMTCT); 2015- 2021 (Percentage, %)
Figure 103: Advanced Economies and Emerging Market & Developing Economies GDP Per Capita; 2018-2027 (US$ Thousand)
Figure 104: HIV Funding from Donor Governments; 2015-2021 (US$ Billion)
Figure 105: The US Federal Domestic Discretionary Funding for HIV/AIDS; 2021-2024 (US$ Million)
Figure 106: Global Artificial Intelligence (AI) Market Revenues; 2020-2023 (US$ Billion)
Table 2: Global HIV Treatment Market Players: Approved Product List; 2022
Figure 107: Gilead Sciences, Inc. Sales by Product; 2022 (Percentage, %)
Figure 108: GlaxoSmithKline Plc Sales by Products; 2022 (Percentage, %)
Figure 109: Merck & Co., Inc. Sales by Segments; 2022 (Percentage, %)
Figure 110: Abbott Laboratories Revenue by Category; 2022 (Percentage, %)
Figure 111: AbbVie Inc. Net revenue by Regions; 2022 (Percentage, %)
Figure 112: TEVA Pharmaceutical Industries Ltd., Revenues by Segment; 2021 (Percentage, %)
Figure 113: Johnson & Johnson Sales by Business Segment; 2022 (Percentage, %)
Figure 114: Boehringer Ingelheim Net Sales by Business; 2022 (Percentage, %)
Figure 115: Cipla Limited Revenue by Segment; 2022 (Percentage, %)
Figure 116: Viatris Inc. Net Sales by Segment; 2022 (Percentage, %)
Figure 117: Bristol-Myers Squibb Company Revenue by Product; 2022 (Percentage, %)

List of Tables

Table 1: FDA-Approved Generic Drugs For HIV Treatment; Until 2022
  • Global Abacavir Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Abacavir market: According to our latest research, the global Abacavir market looks promising in the next 5 years. As of 2022, the global Abacavir market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Abacavir market, with a systematical descriptio......
  • Global Abacavir Market Research Report 2023
    Published: 05-Dec-2023        Price: US 2900 Onwards        Pages: 85
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Abacavir market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - GSK - Aurobindo - Novnauki - Smilax - Hycultec - Atripla Segment by Type - Tablet Abacavir - Oral Solution Abacavir S......
  • Global Zidovudine Market Research Report 2023, Forecast to 2028
    Published: 22-Nov-2023        Price: US 2680 Onwards        Pages: 136
    Zidovudine is used along with other medications to treat human immunodeficiency virus (HIV) infection. Zidovudine is given to HIV-positive pregnant women to reduce the chance of passing the infection to the baby. Zidovudine is in a class of medications called nucleoside reverse transcriptase inhibitors (NRTIs). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (m......
  • Global Zidovudine Professional Survey Report 2023, Forecast to 2028
    Published: 22-Nov-2023        Price: US 3280 Onwards        Pages: 104
    Zidovudine is used along with other medications to treat human immunodeficiency virus (HIV) infection. Zidovudine is given to HIV-positive pregnant women to reduce the chance of passing the infection to the baby. Zidovudine is in a class of medications called nucleoside reverse transcriptase inhibitors (NRTIs). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (m......
  • Global Abacavir Sulfate Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 29-Aug-2023        Price: US 3380 Onwards        Pages: 127
    Market Overview of Global Abacavir Sulfate market: According to our latest research, the global Abacavir Sulfate market looks promising in the next 5 years. As of 2022, the global Abacavir Sulfate market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Abacavir Sulfate market......
  • Global Zidovudine Market Insights, Forecast to 2029
    Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 75
    Zidovudine (ZDV), also known as azidothymidine (AZT), is an antiretroviral medication used to prevent and treat HIV/AIDS. It is generally recommended for use with other antiretrovirals. It may be used to prevent mother-to-child spread during birth or after a needlestick injury or other potential exposure. It is sold both by itself and together as lamivudine/zidovudine and abacavir/lamivudine/zidovudine. It can be used by mouth or by slow injection into a vein. The global Zidovudin......
  • Global HIV Drugs Market Insights, Forecast to 2029
    Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 93
    HIV is a type of retrovirus that causes serious complications in humans. It generally spreads via the blood, semen, vaginal fluid, pre-ejaculate, or breast milk. The global market for HIV drugs is envisaged to surpass USD 19,000 million by 2019 owing to the recent rise in HIV patient population. The global HIV Drugs market is projected to grow from US$ 23910 million in 2023 to US$ 26950 million by 2029, at a Compound Annual Growth Rate (CAGR) of 2.0% during the forecast period.......
  • HIV Treatment Drugs Industry Forecasts - China Focus
    Published: 24-Jul-2023        Price: US 1800 Onwards        Pages: 91
    This study focuses on China's HIV Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services.......
  • HIV Treatment Drugs Markets in China
    Published: 24-Jul-2023        Price: US 4000 Onwards        Pages: 225
    China's demand for HIV Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, ind......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs